Press "Enter" to skip to content

FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

The decision comes about two months after an FDA advisory panel failed to reach a consensus over whether the once-daily oral drug, sotagliflozin, should be approved as an add-on to insulin therapy.

Original source: https://health.economictimes.indiatimes.com/news/pharma/fda-rejects-sanofi-lexicon-add-on-pill-for-type-1-diabetes/68531273?utm_source=RSS&utm_medium=ETRSS

Also Read:   Suicide attempts rising among black teens